198 related articles for article (PubMed ID: 29807521)
1. QSAR and Pharmacophore Mapping Studies on Benzothiazinimines to Relate their Structural Features with anti-HIV Activity.
Geethaavacini G; Poh GP; Yan LY; Deepashini R; Shalini S; Harish R; Sureshkumar K; Ravichandran V
Med Chem; 2018; 14(7):733-740. PubMed ID: 29807521
[TBL] [Abstract][Full Text] [Related]
2. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
[TBL] [Abstract][Full Text] [Related]
3. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
Sharma MC
Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
[TBL] [Abstract][Full Text] [Related]
4. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
[TBL] [Abstract][Full Text] [Related]
5. Ligand based validated comparative chemometric modeling and pharmacophore mapping of aurone derivatives as antimalarial agents.
Adhikari N; Halder AK; Mondal C; Jha T
Curr Comput Aided Drug Des; 2013 Sep; 9(3):417-32. PubMed ID: 24010937
[TBL] [Abstract][Full Text] [Related]
6. A Structure-Activity Relationship Study of Imidazole-5-Carboxylic Acid Derivatives as Angiotensin II Receptor Antagonists Combining 2D and 3D QSAR Methods.
Sharma MC
Interdiscip Sci; 2016 Mar; 8(1):1-10. PubMed ID: 26202941
[TBL] [Abstract][Full Text] [Related]
7. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
Halder AK; Saha A; Saha KD; Jha T
J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
[TBL] [Abstract][Full Text] [Related]
8. Prospective QSAR-Based Prediction Models with Pharmacophore Studies of Oxadiazole-Substituted α-Isopropoxy Phenylpropanoic Acids with Dual Activators of PPARα and PPARγ.
Sharma MC
Interdiscip Sci; 2015 Dec; 7(4):335-45. PubMed ID: 26178333
[TBL] [Abstract][Full Text] [Related]
9. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
Aher RB; Roy K
Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
[TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents.
Chen KX; Xie HY; Li ZG; Gao JR
Bioorg Med Chem Lett; 2008 Oct; 18(20):5381-6. PubMed ID: 18835162
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors.
Teixeira C; Barbault F; Rebehmed J; Liu K; Xie L; Lu H; Jiang S; Fan B; Maurel F
Bioorg Med Chem; 2008 Mar; 16(6):3039-48. PubMed ID: 18226912
[TBL] [Abstract][Full Text] [Related]
12. Exploring QSAR and pharmacophore mapping of structurally diverse selective matrix metalloproteinase-2 inhibitors.
Halder AK; Saha A; Jha T
J Pharm Pharmacol; 2013 Oct; 65(10):1541-54. PubMed ID: 24028622
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors.
Reddy KK; Singh SK; Dessalew N; Tripathi SK; Selvaraj C
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):339-47. PubMed ID: 21699459
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads.
Vadivelan S; Deeksha TN; Arun S; Machiraju PK; Gundla R; Sinha BN; Jagarlapudi SA
Eur J Med Chem; 2011 Mar; 46(3):851-9. PubMed ID: 21272964
[TBL] [Abstract][Full Text] [Related]
15. QSAR modeling for quinoxaline derivatives using genetic algorithm and simulated annealing based feature selection.
Ghosh P; Bagchi MC
Curr Med Chem; 2009; 16(30):4032-48. PubMed ID: 19747124
[TBL] [Abstract][Full Text] [Related]
16. QSAR study and VolSurf characterization of anti-HIV quinolone library.
Filipponi E; Cruciani G; Tabarrini O; Cecchetti V; Fravolini A
J Comput Aided Mol Des; 2001 Mar; 15(3):203-17. PubMed ID: 11289075
[TBL] [Abstract][Full Text] [Related]
17. Designing hypothesis of substituted benzoxazinones as HIV-1 reverse transcriptase inhibitors: QSAR approach.
Veerasamy R; Subramaniam DK; Chean OC; Ying NM
J Enzyme Inhib Med Chem; 2012 Oct; 27(5):693-707. PubMed ID: 21961709
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR studies on UDP-glucuronosyltransferase 2B7 substrates using the pharmacophore and VolSurf approaches.
Ako R; Dong D; Wu B
Xenobiotica; 2012 Sep; 42(9):891-900. PubMed ID: 22494439
[TBL] [Abstract][Full Text] [Related]
19. Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach.
Ravichandran V; Prashantha Kumar BR; Sankar S; Agrawal RK
Eur J Med Chem; 2009 Mar; 44(3):1180-7. PubMed ID: 18687505
[TBL] [Abstract][Full Text] [Related]
20. QSAR Studies on Neuraminidase Inhibitors as Anti-influenza Agents.
Veerasamy R; Rajak H
Turk J Pharm Sci; 2021 Apr; 18(2):151-156. PubMed ID: 33900700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]